SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs >

Abbvie (ABBV)

ABBV RSS Feed
Add ABBV Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 2/17/2017 10:13:36 AM - Followers: 37 - Board type: Free - Posts Today: 0

ABBV is the branded-pharmaceuticals business formely
owned by Abbott that is now fully independent.


ABBV Investor Relations

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ABBV
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ABBV News: Annual Report (10-k) 02/17/2017 12:22:32 PM
ABBV News: AbbVie Announces $5 Billion Increase to Stock Repurchase Program 02/17/2017 08:00:00 AM
ABBV News: AbbVie Declares Quarterly Dividend 02/17/2017 01:14:00 AM
ABBV News: AbbVie Declares Quarterly Dividend 02/16/2017 12:41:00 PM
ABBV News: AbbVie to Present at the Cowen and Company 37th Annual Health Care Conference 02/15/2017 08:01:00 AM
PostSubject
#290  Sticky Note ABBV/ENTA report 8w Glecaprevir/Pibrentasvir phase-3 data from three trials: DewDiligence 11/11/16 08:48:34 AM
#308   ABBV authorizes new $5B buyback: DewDiligence 02/17/17 10:13:36 AM
#307   UK National Institute For Health And Care Excellence trendmkr 02/16/17 02:40:11 PM
#306   Xeljanz shows mixed outcomes in phase-4 comparisons to DewDiligence 02/16/17 01:44:13 PM
#305   FDA grants priority review for G/P regimen: #msg-128359345. DewDiligence 02/02/17 08:21:15 AM
#304   I stand corrected 4.2% yield lloyd Banks 01/31/17 04:04:46 PM
#303   You said 4% HAHAHAHAHAHAHHAAHAHHAAHHA MikeBK205 01/31/17 03:53:38 PM
#302   It will enter the MJ market when it lloyd Banks 01/27/17 08:51:21 PM
#301   CHMP approves AMGN’s Humira FoB: #msg-128199069. DewDiligence 01/27/17 10:45:34 AM
#300   ABBV reports 4Q16 results: DewDiligence 01/27/17 09:10:53 AM
#298   That's not what The Street, Cramers, Msnbs says MikeBK205 01/25/17 07:52:42 PM
#297   It isn't. You must be on the wrong board. DewDiligence 01/25/17 07:46:33 PM
#296   Why is this considered a marijuana stock? MikeBK205 01/25/17 07:06:54 PM
#295   EMA grants accelerated assessment for G/P HCV regimen: #msg-128090944. DewDiligence 01/24/17 10:17:48 AM
#294   ABBV JPM slides: DewDiligence 01/11/17 11:30:44 AM
#293   Imbruvica shows impressive activity in CLL/SLL after 5 years: DewDiligence 12/03/16 08:23:08 PM
#292   MRK’s 3-DAA HCV regimen fails to impress: #msg-126517784. DewDiligence 11/13/16 10:44:09 AM
#291   ABBV makes this bit.ly/2frudVN Stock Screen : Top dividend ValueInvestor15 11/11/16 12:55:47 PM
#290   ABBV/ENTA report 8w Glecaprevir/Pibrentasvir phase-3 data from three trials: DewDiligence 11/11/16 08:48:34 AM
#289   USPTO rules for ABBV—against CHRS—on Humira ‘166 patent: DewDiligence 11/07/16 12:35:46 PM
#288   ABBV reports 3Q16 results: DewDiligence 10/28/16 08:04:54 AM
#287   AMGN not launching Amjevita—(Humira FoB)—until 2018 or later: DewDiligence 10/27/16 06:47:26 PM
#286   Musings on GILD’s POLARIS studies of 3-DAA HCV regimen: DewDiligence 10/20/16 12:22:22 PM
#285   Leerink initiated AbbVie ABBV at Market Perform. Agree... ValueInvestor15 10/18/16 11:03:06 AM
#284   ABBV/ENTA's second-generation HCV regimen gets FDA BTD for DewDiligence 09/30/16 08:20:09 AM
#283   FDA approves AMGN’s Humira biosimilar: DewDiligence 09/23/16 07:14:06 PM
#280   2Q16 Harvoni/Viekira/Zepatier sales in US/EU/Japan: #msg-124194472. DewDiligence 07/29/16 02:34:39 PM
#279   ABBV 2Q16 results: DewDiligence 07/29/16 09:40:23 AM
#278   AbbVie (ABBV), also reporting Friday, is still ahead fuzzy 07/24/16 08:31:50 AM
#277   FDA approves Humira for NIU: DewDiligence 06/30/16 09:18:29 PM
#276   Most investors think they did, evidently. DewDiligence 06/06/16 10:55:12 AM
#275   Did AbbVie Overpay For Stemcentrx In The $10 venturecapp 06/06/16 10:54:17 AM
#274   ABBV R&D Day slides (247 pages); DewDiligence 06/03/16 09:32:13 AM
#273   FDA approves Zinbryta (daclizumab) for MS: DewDiligence 05/27/16 06:18:05 PM
#272   Yeah I saw that and it def stood PennyStockPickz 04/30/16 02:25:32 PM
#271   ABBV acquires Stemcentryx for $5.8B in cash & DewDiligence 04/28/16 09:29:14 AM
#270   ABBV inked two oncology deals today: DewDiligence 04/21/16 04:17:49 PM
#269   Global phase-3 program for ABT-493/ABT-530 (10 phase-3 trials, DewDiligence 04/19/16 03:41:05 PM
#268   Twitter poll re ABBV's priority-review voucher: DewDiligence 04/18/16 04:03:11 PM
#267   ABT-493/ABT-530 data released today are as good as DewDiligence 04/16/16 11:28:53 AM
#266   FDA approves Imbruvica for first-line CLL: DewDiligence 03/04/16 01:29:56 PM
#265   $ABBV Daily and Weekly Charts http://www.stock $Pistol Pete$ 02/18/16 09:32:32 PM
#264   Partial funding by ABBV: north40000 02/18/16 10:54:31 AM
#263   $ABBV Daily Chart http://www.stockcharts.com/c $Pistol Pete$ 02/14/16 05:25:32 PM
#262   Two IPOs to Kick off 2016 in Biotech nyctraydr 02/10/16 01:54:26 PM
#261   4Q15 V-Pak sales $554M: #msg-120164111. DewDiligence 01/29/16 07:59:36 AM
#260   FDA approves MRK’s HCV combo with recommended RAV DewDiligence 01/28/16 06:27:02 PM
#259   Phase-3 program for ABT-494 in RA: #msg-119708677. DewDiligence 01/08/16 03:44:07 PM
#258   MRK’s HCV regimen delayed slightly in EU: #msg-119266731. DewDiligence 12/18/15 10:26:50 AM
#257   FDA accepts NDA for qD formulation of V-Pak: #msg-118870098. DewDiligence 12/02/15 09:46:19 AM
#256   ABT-493/ABT-530 phase-2b data from AASLD: #msg-118523846. DewDiligence 11/16/15 09:59:52 AM
PostSubject